FDA panel urges approval for Pfizer arthritis drug

Your Health Matters

FDA urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant PfizerAn advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.

facebookShare on Facebook